KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 237, doi. 10.1002/med.21925
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2023 AND VI 43 AND IP 1
Results: 6
1
2
The application of zebrafish patient‐derived xenograft tumor models in the development of antitumor agents.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 212, doi. 10.1002/med.21924
- By:
- Publication type:
- Article
3
Recent advances in dopamine D<sub>2</sub> receptor ligands in the treatment of neuropsychiatric disorders.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 55, doi. 10.1002/med.21923
- By:
- Publication type:
- Article
4
Toward the next generation of vascularized human neural organoids.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 31, doi. 10.1002/med.21922
- By:
- Publication type:
- Article
5
ER stress and inflammation crosstalk in obesity.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 5, doi. 10.1002/med.21921
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 1, doi. 10.1002/med.21895
- Publication type:
- Article